|
Re: AGMs
|
4
|
Resverlogix Corp.
|
Oct 31, 2019 03:03PM
|
|
Re: ALP Levels Predict Adverse Cardiovascular Outcomes And Cognitive Impairment In High Risk Patients
|
8
|
Resverlogix Corp.
|
Aug 08, 2019 02:15PM
|
|
Re: Alzheimer's news
|
6
|
Resverlogix Corp.
|
Nov 04, 2019 04:14PM
|
|
Re: Angiotensin and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:20PM
|
|
Re: Another article
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 01:35PM
|
|
Re: Apabetalone and Alkaline Phosphatase
|
3
|
Resverlogix Corp.
|
Oct 12, 2019 11:36AM
|
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
3
|
Resverlogix Corp.
|
Jun 12, 2020 12:23AM
|
|
Re: Apabetalone recudes ALP (apologies if repeat. looked on the new side)
|
9
|
Resverlogix Corp.
|
Jun 11, 2020 12:30AM
|
|
Re: archived presentation is up. still no audio
|
3
|
Resverlogix Corp.
|
Nov 18, 2019 02:12PM
|
|
Re: ask Don?
|
8
|
Resverlogix Corp.
|
Oct 29, 2019 12:00PM
|
|
Re: balancing success and failure
|
4
|
Resverlogix Corp.
|
Nov 19, 2019 08:59PM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 19, 2019 10:37PM
|
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:13AM
|
|
Re: balancing success and failure
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 12:34AM
|
|
Re: balancing success and failure
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 12:38PM
|
|
Re: balancing success and failure
|
5
|
Resverlogix Corp.
|
Nov 20, 2019 01:59PM
|
|
Re: BD2 specific inhibitors mentioned in Science
|
4
|
Resverlogix Corp.
|
Mar 22, 2020 01:46PM
|
|
Re: BETonMACE summary from Webcast 11/18/19
|
2
|
Resverlogix Corp.
|
Nov 18, 2019 01:46PM
|
|
Re: BIO CEO Slides Up
|
2
|
Resverlogix Corp.
|
Sep 18, 2019 07:00PM
|
|
Re: BOM 2 Trial
|
5
|
Resverlogix Corp.
|
Jun 10, 2020 12:12PM
|
